Perkins Coie Trust Co - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.

Quarter-by-quarter ownership
Perkins Coie Trust Co ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53
-57.3%
1780.0%0.00%
Q2 2023$124
-21.5%
1780.0%0.00%
Q1 2023$158
-24.0%
1780.0%0.00%
Q4 2022$208
-79.2%
1780.0%0.00%
Q3 2022$1,0000.0%1780.0%0.00%
Q2 2022$1,0000.0%1780.0%0.00%
Q1 2022$1,0000.0%1780.0%0.00%
Q4 2021$1,0000.0%1780.0%0.00%
Q3 2021$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2021$2,0000.0%1780.0%0.00%0.0%
Q1 2021$2,0000.0%1780.0%0.00%0.0%
Q4 2020$2,000
+100.0%
1780.0%0.00%
Q3 2020$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2020$2,000
+100.0%
1780.0%0.00%0.0%
Q1 2020$1,000
-66.7%
1780.0%0.00%0.0%
Q4 2019$3,000
+50.0%
1780.0%0.00%0.0%
Q3 2019$2,0000.0%1780.0%0.00%0.0%
Q2 2019$2,0000.0%1780.0%0.00%0.0%
Q1 2019$2,0000.0%1780.0%0.00%0.0%
Q4 2018$2,0000.0%1780.0%0.00%0.0%
Q3 2018$2,0000.0%1780.0%0.00%0.0%
Q2 2018$2,0000.0%1780.0%0.00%0.0%
Q1 2018$2,0000.0%1780.0%0.00%0.0%
Q4 2017$2,0000.0%1780.0%0.00%0.0%
Q3 2017$2,000
+100.0%
1780.0%0.00%0.0%
Q2 2017$1,000
-50.0%
1780.0%0.00%0.0%
Q1 2017$2,0001780.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders